Digestive Diseases
FOMAT Prime Therapeutic Areas provide highly specialized research sites with strong infrastructure, expert investigators, and proven recruitment models. In Digestive Diseases, we support trials across NAFLD, MASH, IBD, GERD, and related conditions with full diagnostic capabilities and access to diverse patients
Patients accessible through EMR
Locations (sites and FQHCs) with full digestive trial capabilities
Advanced diagnostic technologies fully integrated
Diverse patient enrollment
Digestive Diseases Clinical Trial Capabilities
Our digestive clinical trial capabilities include fully equipped endoscopy and imaging facilities, experienced research teams, and tailored operational support across all phases. We ensure consistent trial delivery with access to diverse patient populations and specialized infrastructure
Full on-site diagnostic suite for digestive trials (Fibroscan, Colonoscopy, Capsule Endoscopy, Bravo pH Testing, MRE/MRI-PDFF, Liver Biopsy)
Dedicated SOPs and quality control processes for Digestive studies
Multi-location patient access across California clinical sites
Integrated EHR, CTMS, eSource, eConsent, and remote monitoring systems
Specialized community engagement and recruitment teams targeting metabolic populations
Experienced research teams trained in advanced metabolic protocols and complex clinical trial execution
Key Differentiators
Reliable Start-Up Execution
Dedicated regulatory, contracting, and start-up teams streamline site activation and ensure predictable study launch timelines
Experienced Digestive Investigators
Board-certified investigators with extensive clinical research experience in NAFLD, MASH, IBD, GERD, and digestive disorders
Real-Time Data Management
Integrated platforms (EHR, CTMS, eSource, eConsent) enable continuous data monitoring, query resolution, and sponsor access to clean, timely data
Comprehensive Recruitment & Retention
In-house patient engagement teams manage end-to-end recruitment, pre-screening, and retention processes across diverse digestive populations
Infrastructure for All Study Phases
Fully equipped clinical sites support early-phase through late-phase digestive trials with on-site diagnostics, imaging, and biospecimen capabilities
Leading Sites for Digestive Research
End-to-end capabilities for complex digestive studies
